| NCT ID | NCT07564960 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Arizona |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-04-27 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-04-27 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study tests whether clinical interventions to optimize support receptivity lead to improvements in social integration and quality of life (QOL) amongst long-term lung cancer survivors. The feasibility and acceptability of the intervention and assessment procedures will be examined. Thirty long-term lung cancer survivors will be randomized to a support receptivity intervention or an attention-control condition. Our intervention draws on cognitive behavioral therapy (CBT) strategies to reduce social anxiety, improve social awareness, and promote social integration. We will use two novel in vivo sampling methods using a mobile phone platform to assess social engagement and QOL improvements: 1) recording via the Electronically Activated Recorder to capture daily social interactions, and 2) repeated self-report sampling where participants answer questions about their social engagement experiences via their personal cell phone.
Eligibility Criteria
Inclusion Criteria: 1. Adults (18 Years or Older) 2. History of lung cancer 3. at least 12 months since cancer diagnosis 4. fluent in English 5. able to attend virtually or in person sessions at the University of Arizona. Exclusion Criteria: 1. Less than 12 months of cancer diagnosis at time of enrollment 2. undergoing treatment for mood or anxiety health issues at time of enrollment 3. unable to provide informed consent.
Contact & Investigator
Scott Carvajal, PhD, MPH
PRINCIPAL INVESTIGATOR
University of Arizona
Frequently Asked Questions
Who can join the NCT07564960 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07564960 currently recruiting?
Yes, NCT07564960 is actively recruiting participants. Contact the research team at fmoraleslozada@arizona.edu for enrollment information.
Where is the NCT07564960 trial being conducted?
This trial is being conducted at Tucson, United States.
Who is sponsoring the NCT07564960 clinical trial?
NCT07564960 is sponsored by University of Arizona. The principal investigator is Scott Carvajal, PhD, MPH at University of Arizona. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.